Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Lower versus higher fluid volumes during initial management of sepsis - a systematic review with meta-analysis and trial sequential analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Response

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. International Severe Asthma Registry: Mission Statement

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. The Magic Bullet in Sepsis or the Inflation of Chance Findings?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. A Scoring Application for the St. George's Respiratory Questionnaire

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Characteristics of Undertreatment in COPD in the General Population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Lactate versus acetate buffered intravenous crystalloid solutions: a scoping review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Evaluating Non-Statistically Significant Results From Trials in Practice-Reply

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

PURPOSE: Intravenous fluids are recommended during the initial management of sepsis, but the quality of evidence is low, and clinical equipoise exists. We aimed to assess patient-important benefits and harms of lower versus higher fluid volumes in adult patients with sepsis.

METHODS: We conducted a systematic review with meta-analysis and trial sequential analysis (TSA) of randomised clinical trials of intravenous fluid volume separation in adult patients with sepsis. We adhered to our published protocol, the Cochrane Handbook, the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, and the Grading of Recommendations Assessment, Development and Evaluation statements. The primary outcomes were all-cause mortality, serious adverse events and quality-of-life.

RESULTS: We included 9 trials (n=637); all were published after 2015 and had overall high risk of bias. We found no statistically significant difference between lower versus higher fluid volumes on all-cause mortality (relative risk 0.87, 95% confidence interval (CI) 0.69 to 1.10, I2=0%; TSA adjusted Cl 0.34 to 2.22), or serious adverse events (relative risk 0.91 95% CI 0.78 to 1.05, I2=0%; TSA adjusted CI 0.68 to 1.21). No trials reported on quality-of-life. We did not find differences in the secondary or exploratory outcomes. The quality of evidence was very low across all outcomes.

CONCLUSIONS: In this systematic review, we found very low quantity and quality of evidence supporting the decision on the volumes of IV fluid therapy in adults with sepsis.

OriginalsprogEngelsk
Artikelnummerpii: S0012-3692
TidsskriftChest
Vol/bind20
Sider (fra-til)30123-9
ISSN0012-3692
DOI
StatusUdgivet - 23 jan. 2020

Bibliografisk note

Copyright © 2020. Published by Elsevier Inc.

ID: 59134941